DMD research nears clinical trials

Researchers affiliated with Brown University and Tivorsan Pharmaceuticals Inc. in Providence are moving toward clinical trials of a treatment to combat Duchenne Muscular Dystrophy, the most common form of muscular dystrophy that kills males in young adulthood. More

This item is available in full to subscribers. If you are a current subscriber, log in to continue.

Otherwise, purchase a subscription to continue.

You can also purchase this single article, if you prefer. Click here to continue.